What the Evidence Shows and What It Does Not The Gallup obesity and GLP-1 data are drawn from self-reported surveys, which introduces known limitations
[8] [9] People taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycaemia
All research involving this material should be conducted by qualified professionals in properly equipped laboratory facilities and in accordance with applicable regulations
What are the impacts on the wider economy of a drug that is nearly as effective as bariatric surgery and acts via, primarily, appetite reduction
Both responses are typical
G., Yang, J., Santra, S., Santra, S., Chopp, M., & Morris, D